David Granlund () and Miyase Yesim Köksal ()
Additional contact information
David Granlund: Department of Economics, Umeå University, Postal: S 901 87 Umeå, Sweden
Miyase Yesim Köksal: Department of Economics, School of Business, Economics and Law, Postal: University of Gothenburg, SE-405 30 Gothenburg, Sweden
Abstract: What has been the effect of competition from parallel imports on prices of locally-sourced on-patent drugs? Did the 2002 Swedish mandatory substitution reform increase this competition? To answer these questions, we carried out difference-in-differences estimation on monthly data for a panel of all on-patent prescription drugs sold in Sweden during the 40 months from January 2001 through April 2004. On average, facing competition from parallel imports caused a 15-17% fall in price. While the reform increased the effect of competition from parallel imports, it was only by 0.9%. The reform, however, did increase the effect of therapeutic competition by 1.6%.
Keywords: parallel imports; pharmaceutical drugs; price competition; reference pricing; therapeutic competition
32 pages, April 13, 2011
Full text files
DownloadAsset.action...Id=3&assetKey=ues824
Questions (including download problems) about the papers in this series should be directed to David Skog ()
Report other problems with accessing this service to Sune Karlsson ().
This page generated on 2024-02-05 17:13:52.